Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13345
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hirunsai M. | |
dc.contributor.author | Yimlamai T. | |
dc.contributor.author | Suksamrarn A. | |
dc.date.accessioned | 2021-04-05T03:23:23Z | - |
dc.date.available | 2021-04-05T03:23:23Z | - |
dc.date.issued | 2016 | |
dc.identifier.issn | 0258851X | |
dc.identifier.other | 2-s2.0-84994246675 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13345 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994246675&doi=10.21873%2finvivo.11007&partnerID=40&md5=6a1b5fcb0dcc58301598696d69588ae3 | |
dc.description.abstract | Background/Aim: 20-Hydroxyecdystone (20E) is an ecdysteroid hormone which controls molting and reproduction in arthropods. 20E also produces a variety of effects in vertebrates, including enhancing protein synthesis and skeletal muscle regeneration. The effect of 20E on disuse muscle atrophy has not been reported to date. This study examined the proteolytic regulation of 20E in tenotomized rat slow soleus and fast plantaris muscles. Materials and Methods: Male Wistar rats were randomly divided into three groups: sedentary control (CON), tenotomy without 20E treatment (TEN), and tenotomy with treatment of 5 mg/kg BW of 20E (TEN+20E). The TEN+20E group was administered 20E via subcutaneous injection to the right thigh for 7 days after tenotomy. Results: 20E treatment tended to attenuate disuse muscle atrophy and reduced ubiquitination only in soleus muscle. Conclusion: 20E treatment alleviates skeletal muscle atrophy partially mediated by ubiquitinate pathway, dependent on the muscle phenotype. © 2016, International Institute of Anticancer Research. All rights reserved. | |
dc.subject | ecdysterone | |
dc.subject | muscle protein | |
dc.subject | muscle RING finger 1 protein | |
dc.subject | ecdysterone | |
dc.subject | ubiquitinated protein | |
dc.subject | achilles tendon | |
dc.subject | adult | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | body weight | |
dc.subject | controlled study | |
dc.subject | histology | |
dc.subject | male | |
dc.subject | muscle atrophy | |
dc.subject | muscle mass | |
dc.subject | muscle wet weight | |
dc.subject | nonhuman | |
dc.subject | plantaris muscle | |
dc.subject | protein degradation | |
dc.subject | protein expression | |
dc.subject | rat | |
dc.subject | skeletal muscle | |
dc.subject | soleus muscle | |
dc.subject | tenotomy | |
dc.subject | ubiquitination | |
dc.subject | Western blotting | |
dc.subject | animal | |
dc.subject | drug effects | |
dc.subject | metabolism | |
dc.subject | muscle atrophy | |
dc.subject | pathology | |
dc.subject | protein degradation | |
dc.subject | randomization | |
dc.subject | signal transduction | |
dc.subject | skeletal muscle | |
dc.subject | subcutaneous drug administration | |
dc.subject | Wistar rat | |
dc.subject | Animals | |
dc.subject | Blotting, Western | |
dc.subject | Ecdysterone | |
dc.subject | Injections, Subcutaneous | |
dc.subject | Male | |
dc.subject | Muscle, Skeletal | |
dc.subject | Muscular Atrophy | |
dc.subject | Proteolysis | |
dc.subject | Random Allocation | |
dc.subject | Rats, Wistar | |
dc.subject | Signal Transduction | |
dc.subject | Tenotomy | |
dc.subject | Ubiquitinated Proteins | |
dc.subject | Ubiquitination | |
dc.title | Effect of 20-hydroxyecdysone on proteolytic regulation in skeletal muscle atrophy | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | In Vivo. Vol 30, No.6 (2016), p.869-877 | |
dc.identifier.doi | 10.21873/invivo.11007 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.